| Systematic review: treatment agreements and urine drug testing to reduce opioid misuse in patients with chronic pain JL Starrels, WC Becker, DP Alford, A Kapoor, AR Williams, BJ Turner Annals of internal medicine 152 (11), 712-720, 2010 | 365 | 2010 |
| Development of a cascade of care for responding to the opioid epidemic AR Williams, EV Nunes, A Bisaga, FR Levin, M Olfson The American journal of drug and alcohol abuse 45 (1), 1-10, 2019 | 266 | 2019 |
| Risk factors for discontinuation of buprenorphine treatment for opioid use disorders in a multi-state sample of Medicaid enrollees H Samples, AR Williams, M Olfson, S Crystal Journal of substance abuse treatment 95, 9-17, 2018 | 176 | 2018 |
| Developing an opioid use disorder treatment cascade: a review of quality measures AR Williams, EV Nunes, A Bisaga, HA Pincus, KA Johnson, AN Campbell, ... Journal of substance abuse treatment 91, 57-68, 2018 | 155 | 2018 |
| Acute care, prescription opioid use, and overdose following discontinuation of long-term buprenorphine treatment for opioid use disorder AR Williams, H Samples, S Crystal, M Olfson American Journal of Psychiatry 177 (2), 117-124, 2020 | 131 | 2020 |
| Older, less regulated medical marijuana programs have much greater enrollment rates than newer ‘medicalized’programs AR Williams, M Olfson, JH Kim, SS Martins, HD Kleber Health Affairs 35 (3), 480-488, 2016 | 97 | 2016 |
| From AIDS to opioids—how to combat an epidemic AR Williams, A Bisaga New England Journal of Medicine 375 (9), 813-815, 2016 | 87 | 2016 |
| To battle the opioid overdose epidemic, deploy the ‘cascade of care’model A Williams, E Nunes, M Olfson | 69 | 2017 |
| Loose regulation of medical marijuana programs associated with higher rates of adult marijuana use but not cannabis use disorder AR Williams, J Santaella‐Tenorio, CM Mauro, FR Levin, SS Martins Addiction 112 (11), 1985-1991, 2017 | 67 | 2017 |
| A review of a national training initiative to increase provider use of MAT to address the opioid epidemic FR Levin, A Bisaga, MA Sullivan, AR Williams, K Cates‐Wessel The American journal on addictions 25 (8), 603-609, 2016 | 67 | 2016 |
| Effect of methylphenidate on apathy in patients with Alzheimer disease: the ADMET 2 randomized clinical trial J Mintzer, KL Lanctôt, RW Scherer, PB Rosenberg, N Herrmann, ... JAMA neurology 78 (11), 1324-1332, 2021 | 65 | 2021 |
| Impact Of Long-Term Buprenorphine Treatment On Adverse Health Care Outcomes In Medicaid: The impact of longer treatment on health care outcomes for opioid use disorder within a … H Samples, AR Williams, S Crystal, M Olfson Health Affairs 39 (5), 747-755, 2020 | 54 | 2020 |
| Cannabis as a gateway drug for opioid use disorder AR Williams The Journal of Law, Medicine & Ethics 48 (2), 268-274, 2020 | 49 | 2020 |
| Assessing and improving clinical insight among patients “in denial” AR Williams, M Olfson, M Galanter JAMA psychiatry 72 (4), 303-304, 2015 | 39 | 2015 |
| Outcomes among buprenorphine-naloxone primary care patients after Hurricane Sandy B Tofighi, E Grossman, AR Williams, R Biary, J Rotrosen, JD Lee Addiction science & clinical practice 9, 1-7, 2014 | 34 | 2014 |
| Article Commentary: Research Priorities for Expanding access to Methadone Treatment for Opioid use Disorder in the United States: A National Institute on Drug Abuse Clinical … PJ Joudrey, G Bart, RK Brooner, L Brown, J Dickson-Gomez, A Gordon, ... Substance Abuse 42 (3), 245-254, 2021 | 30 | 2021 |
| Commitment to assessment and treatment: comprehensive care for patients gravely disabled by alcohol use disorders RP McCormack, AR Williams, LR Goldfrank, AL Caplan, S Ross, ... The Lancet 382 (9896), 995-997, 2013 | 29 | 2013 |
| COVID-19 could change the way we respond to the opioid crisis—for the better Y Bao, AR Williams, BR Schackman Psychiatric Services 71 (12), 1214-1215, 2020 | 26 | 2020 |
| Long‐term follow‐up study of community‐based patients receiving XR‐NTX for opioid use disorders AR Williams, V Barbieri, K Mishlen, FR Levin, EV Nunes, JJ Mariani, ... The American Journal on Addictions 26 (4), 319-325, 2017 | 26 | 2017 |
| Statutory definitions of mental illness for involuntary hospitalization as related to substance use disorders AR Williams, S Cohen, EB Ford Psychiatric Services 65 (5), 634-640, 2014 | 21 | 2014 |
Mark OlfsonElizabeth K Dollard Professor of Psychiatry, Medicine and Law and Professor of EpidemiologyVerified email at nyspi.columbia.edu
